In March, 2026, a Working Group of 12 scientists from nine countries met at the International Agency for Research on Cancer (IARC) in Lyon, France, to finalise their evaluation of the carcinogenicity of tris(chloropropyl) phosphate (TCPP), butyraldehyde, and cumyl hydroperoxide.
The Lancet Oncology published a clinical update in Oncology on 27 Mar 2026. The item focuses on Carcinogenicity of tris(chloropropyl) phosphate, butyraldehyde, and cumyl hydroperoxide. Open the detail page to review the full original feed content.